Efficacy of Adjunctive Cariprazine in Patients With Major Depressive Disorder and Anxiety Symptoms: A Post Hoc Analysis

被引：0
|
作者：
Fava, Maurizio [1 ]
Maletic, Vladimir [1 ]
Chen, Chen [1 ]
Adams, Julie [1 ]
Kramer, Ken [1 ]
Kerolous, Majid [1 ]
机构：
[1] AbbVie, Madison, NJ USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2022年 / 47卷 / SUPPL 1期
关键词：
Cariprazine; Dopamine; Major Depressive Disorder; Anxiety;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P342
引用
收藏
页码：260 / 261
页数：2
相关论文
共 50 条
  • [41] Adjunctive modafinil may improve fatigue and depressive symptoms in major depressive disorder
    不详
    CNS SPECTRUMS, 2004, 9 (11) : 798 - 799
  • [42] Full-spectrum efficacy of cariprazine across manic and depressive symptoms of bipolar I disorder in patients experiencing mood episodes: Post hoc analysis of pooled randomized controlled trial data
    Vieta, Eduard
    Mcintyre, Roger S.
    Yu, Jun
    Aronin, Lauren C.
    Kramer, Ken
    Nguyen, Huy-Binh
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 366 : 136 - 145
  • [43] The clinical correlates of comorbid anxiety symptoms and syndromal anxiety in patients with major depressive disorder
    Wu Zhiguo
    Lan Cao
    Peng Daihui
    Mellor, David
    Chen, Zhang
    Li Haozhe
    Wang Zuowei
    Song Yanyan
    Li Chunbo
    Fang Yiru
    PSYCHIATRY RESEARCH, 2018, 269 : 251 - 257
  • [44] Cariprazine vs risperidone efficacy on predominant negative symptoms of schizophrenia: post hoc analysis of negative symptoms subdomains
    Laszlovszky, I.
    Barabassy, A.
    Szatmari, B.
    Harsanyi, J.
    Szalai, E.
    Nemeth, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S902 - S903
  • [45] Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress
    McIntyre, Roger S.
    Bubolic, Suzy
    Zhang, Zhen
    MacKenzie, Erin M.
    Therrien, Francois
    Miguelez, Maia
    Boucher, Matthieu
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (02) : 133 - 140
  • [46] Discontinuation symptoms in social anxiety disorder, general anxiety disorder, and major depressive disorder
    Baldwin, DS
    Montgomery, SA
    Nil, R
    Lader, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S425 - S426
  • [47] Reduction of anxiety symptoms in patients with major depressive disorder treated with Desvenlafaxine Succinate: A pooled analysis
    Tourian, K. A.
    Ahmed, S.
    Patroneva, A.
    Zitek, B.
    Graepel, J.
    Pitrosky, B.
    EUROPEAN PSYCHIATRY, 2008, 23 : S208 - S208
  • [48] Efficacy of cariprazine on predominant negative symptoms of patients with schizophrenia: post hoc analysis of PANSS data, Marder factors, and cognition
    Marder, S.
    Laszlovszky, I.
    Szalai, E.
    Szatmari, B.
    Harsanyi, J.
    Barabassy, A.
    Debelle, M.
    Durgam, S.
    Bitter, I.
    Nemeth, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S550 - S550
  • [49] Brexpiprazole and aripiprazole for the adjunctive treatment of major depressive disorder: post hoc analysis of completion rates in long-term studies
    Weiss, C.
    Zhang, P.
    Baker, R. A.
    Meehan, S. R.
    Hefting, N.
    Hobart, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S193 - S194
  • [50] Cariprazine's role in major depressive disorder
    Gasparinho, R.
    Fernandes, N.
    Ferreira, L.
    Santos, N.
    Costa, I.
    Alho, A.
    Martins, M.
    Costa, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S518 - S519
12345